Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-01

FDA Tentative Approval: FINGOLIMOD — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA issued tentative approval for a supplemental application for Fingolimod by XLCare Pharmaceuticals Inc., enabling a generic version to enter the market for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL TA for FINGOLIMOD (FINGOLIMOD)